» Articles » PMID: 33962617

Health-related Quality of Life in Chinese Population with Non-alcoholic Fatty Liver Disease: a National Multicenter Survey

Overview
Publisher Biomed Central
Specialty Public Health
Date 2021 May 8
PMID 33962617
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Health Related Quality of Life (HRQL) is a multi-dimensional construct that can comprehensively evaluate the patient's health status, including physical, emotional, mental and social well-being. In this study, we aimed to evaluate the impact of non-alcoholic fatty liver disease (NAFLD) on HRQL in a Chinese population.

Methods: In this national multicenter cross-sectional survey, patients with NAFLD were enrolled. Chronic Liver Disease Questionnaire (CLDQ)-NAFLD was used to qualify HRQL. Univariate and multivariate analysis were used to identify independent risk factors of HRQL.

Results: A total of 5181 patients with NAFLD from 90 centers were enrolled in this study (mean age, 43.8 ± 13.3 years; male, 65.8%). The overall CLDQ score was 5.66 ± 0.89. Multivariate logistic regression analysis showed that body mass index (BMI: HR, 1.642; 95% CI, 1.330-2.026), alanine transaminase (ALT: HR, 1.006; 95% CI, 1.001-1.011), triglyceride (HR, 1.184; 95% CI, 1.074-1.305), disease severity (HR, 3.203; 95% CI, 1.418-7.232) and cardiovascular disease (HR, 4.305; 95% CI, 2.074-8.939) were independent risk factors for overall CLDQ score. In the logistic analyses of individual domain, BMI and triglyceride were independent risk factors of all domains. ALT, disease severity, diabetes, depression and cardiovascular disease were influencing factors for the CLDQ score of several domains.

Conclusions: This national multicenter cross-sectional survey in China indicated that the HRQL in patients with NAFLD was impaired. HRQL was found to be significantly associated with sociodemographic and clinical factors. Attention should be paid to the optimally managing care of patients with NAFLD to improve their HRQL.

Citing Articles

Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).

Fan J, Xu X, Yang R, Nan Y, Wei L, Jia J J Clin Transl Hepatol. 2024; 12(11):955-974.

PMID: 39544247 PMC: 11557364. DOI: 10.14218/JCTH.2024.00311.


Efficacy and safety of electroacupuncture for metabolic dysfunction-associated fatty liver disease: a study protocol for a multicentre, randomised, sham acupuncture-controlled, patient-blinded clinical trial.

Zhao J, Zhao X, Wang Q, Ren H, Cao D, Hu X BMJ Open. 2024; 14(11):e084768.

PMID: 39542484 PMC: 11575283. DOI: 10.1136/bmjopen-2024-084768.


Non-alcoholic fatty liver disease and coexisting depression, anxiety and/or stress in adults: a systematic review and meta-analysis.

Shea S, Lionis C, Kite C, Lagojda L, Uthman O, Dallaway A Front Endocrinol (Lausanne). 2024; 15:1357664.

PMID: 38689730 PMC: 11058984. DOI: 10.3389/fendo.2024.1357664.


Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.

Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y BMC Med. 2024; 22(1):101.

PMID: 38448943 PMC: 10919055. DOI: 10.1186/s12916-024-03315-0.


Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China.

Zhou R, Zhang B, Zhang W, Kong T, Fu J, Li J BMJ Open. 2024; 14(2):e078333.

PMID: 38388505 PMC: 10884200. DOI: 10.1136/bmjopen-2023-078333.


References
1.
Wang F, Fan J, Zhang Z, Gao B, Wang H . The global burden of liver disease: the major impact of China. Hepatology. 2014; 60(6):2099-108. PMC: 4867229. DOI: 10.1002/hep.27406. View

2.
Pan S, Chen X, Shen H, Li X, Cai M, Zhao Y . Retracted: Rapid and effective sample cleanup based on graphene oxide-encapsulated core-shell magnetic microspheres for determination of fifteen trace environmental phenols in seafood by liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2018; 1046:208. DOI: 10.1016/j.aca.2018.10.049. View

3.
David K, Kowdley K, Unalp A, Kanwal F, Brunt E, Schwimmer J . Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009; 49(6):1904-12. PMC: 2692572. DOI: 10.1002/hep.22868. View

4.
Anyayo L, Ashaba S, Kaggwa M, Maling S, Nakimuli-Mpungu E . Health-related quality of life among patients with bipolar disorder in rural southwestern Uganda: a hospital based cross sectional study. Health Qual Life Outcomes. 2021; 19(1):84. PMC: 7945052. DOI: 10.1186/s12955-021-01729-5. View

5.
Ferrer M, Cordoba J, Garin O, Olive G, Flavia M, Vargas V . Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2005; 12(1):95-104. DOI: 10.1002/lt.20551. View